APA (7th ed.) Citation

Poret, B., Desrues, L., Bonin, M., Pedard, M., Dubois, M., Leduc, R., . . . Gandolfo, P. (2020). Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. Biomolecules (2218-273X), 10(3), 471. https://doi.org/10.3390/biom10030471

Chicago Style (17th ed.) Citation

Poret, Benjamin, et al. "Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours." Biomolecules (2218-273X) 10, no. 3 (2020): 471. https://doi.org/10.3390/biom10030471.

MLA (9th ed.) Citation

Poret, Benjamin, et al. "Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours." Biomolecules (2218-273X), vol. 10, no. 3, 2020, p. 471, https://doi.org/10.3390/biom10030471.